Linde’s Q2 2026 sales trajectory reflects steady underlying demand growth in industrial gases amid pricing discipline and modest volume gains. After reporting $8.78 billion in Q1 sales (up 8% YoY, with underlying sales rising 3%), the company guided Q2 adjusted EPS of $4.40–$4.50, implying continued momentum from price attainment and contributions from electronics and hydrogen projects. Full-year 2026 EPS guidance was raised to $17.60–$17.90, incorporating a 1% currency tailwind and assuming stable macro conditions. With earnings scheduled for July 31, trader focus centers on whether sales exceed consensus estimates around $8.6–$8.8 billion, driven by manufacturing end-market trends, backlog execution, and any sequential margin expansion.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado$3.6 mil millones
97%
$3.65 mil millones
96%
$3.7 mil millones
97%
$3.75 mil millones
96%
$3.8 mil millones
97%
$4,865 Vol.
$3.6 mil millones
97%
$3.65 mil millones
96%
$3.7 mil millones
97%
$3.75 mil millones
96%
$3.8 mil millones
97%
The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to "No".
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to "No".
If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.
The resolution source for this market is the specified company's official company earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.
Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
Mercado abierto: Jul 18, 2026, 4:17 PM ET
Resolver
0x65070BE91...The specified metric will be considered as reported in the company's official earnings materials. Subsequent revisions will not be considered.
If the specified company's official earnings materials for the specified quarter are released, and the specified metric is not included, this market will resolve to "No".
If the specified company does not release quarterly earnings materials for the specified quarter by August 31, 2026, 11:59 PM ET, this market will resolve to "No".
If the specified metric is reported as a range rather than a specific number, the midpoint of the range will be used for resolution of this market.
The resolution source for this market is the specified company's official company earnings materials, including press releases, investor presentations, and regulatory filings. If the specified metric is not reported in these materials, recordings or transcripts of the company's earnings webcast may also be used.
Note: This market will resolve based on the most numerically precise version of the specified metric reported in the company's official earnings materials. Only the specified metric will be considered; alternate versions that differ in definition or scope from the specified metric will not be considered.
Resolver
0x65070BE91...Linde’s Q2 2026 sales trajectory reflects steady underlying demand growth in industrial gases amid pricing discipline and modest volume gains. After reporting $8.78 billion in Q1 sales (up 8% YoY, with underlying sales rising 3%), the company guided Q2 adjusted EPS of $4.40–$4.50, implying continued momentum from price attainment and contributions from electronics and hydrogen projects. Full-year 2026 EPS guidance was raised to $17.60–$17.90, incorporating a 1% currency tailwind and assuming stable macro conditions. With earnings scheduled for July 31, trader focus centers on whether sales exceed consensus estimates around $8.6–$8.8 billion, driven by manufacturing end-market trends, backlog execution, and any sequential margin expansion.
Resumen experimental generado por IA con datos de Polymarket. Esto no es asesoramiento de trading y no influye en cómo se resuelve este mercado. · Actualizado



Cuidado con los enlaces externos.
Cuidado con los enlaces externos.
Preguntas frecuentes